global market for Typhoid Treatment

Posted by abhishek jadhav on February 22nd, 2021

global market for Typhoid Treatment was valued at $xx Mn in 2019 and is expected to reach $xx Mn by 2027, at a CAGR of xx%.

Market Introduction and Overview

Typhoid is the most common type of fever in rural and underdeveloped economies. According to WHO, typhoid is an endemic fever in Africa, Latin America, Oceania, and the Caribbean. WHO also states that 80% of the typhoid fever cases arise from countries of the APAC region such as India, China, Bangladesh, Nepal and Indonesia. In 2017, around 494 per 100,000 children of age group 5-15 years suffered from typhoid. The rising cases of typhoid in the APACgion are expected to grow the market size.

Increasing morbidity rates due to typhoid is a major concern. Various manufacturers and non-government organizations are creating awareness and promoting new studies related to the importance of early diagnosis, the innovation of new, potent vaccines to combat typhoid, thereby strengthening the market growth. Increasing vaccine production and the number of candidates in the phases of the clinical trial which are expected to be approved soon are encouraging stakeholders to invest more. Governments of various countries have come up with favorable policies for the treatment of typhoid which is helping patients financially. Also, vaccination and immunization campaigns have been started in respective countries which are propelling the market.

Antibiotics are the only effective treatment for typhoid. The commonly used are ciprofloxacin and ceftriaxone. If the bacteria are antibiotic-resistant, there is a need for surgery. Vaccines and antibiotics can be administered in the oral as well as injectable form. The increase in approval of more medications is helping the market grow northwards.

The report provides a detailed analysis of the Typhoid Treatment market. It includes the recent advances, applications, and ongoing trends globally. Funding for treatments, partnerships between key players, revenue forecasts of companies is also provided in detail in the report. The report also provides information on application areas to help investors invest rightly.

The report has profiled five key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.

Segment Analysis

The medication segment held a share of $xx Mn in 2019 and is expected to grow at a rate of xx% in the forecast period. Antibiotics are the most preferred medications for typhoid treatment.

Global Typhoid Treatment Market

Chloramphenicol has been the drug of choice for typhoid fever for more than 40 years globally, where S.typhi remains susceptible to the drug. However, multiple drug resistance (MDR) to ampicillin, chloramphenicol, and trimethoprim-sulphamethoxazole in S.typhi has emerged in many countries. A number of drug candidates are under clinical trials and are expected to be approved soon by the FDA, which is expected to drive the market high. These medications have fewer or no side effects and hence have high demand. Cephalosporins, ceftriaxone, and cefixime are useful against MDR typhoid fever and are administered intravenously.

Market Segmentation

The Typhoid Treatment Market is segmented based on-

Medications

• Antibiotics

 Chloramphenicol

 Ciprofloxacin

 Ceftriaxone

 Ampicillin

 Trimethoprim-sulfamethoxazole

• Vaccines

 Inactivated(Killed) vaccine

 Live attenuated (weakened) vaccine

Supportive Therapy

• Intravenous Fluids(IV)

• Intravenous Electrolyte Fluids

Regional Insights

Global Typhoid Treatment Market1

North America dominated the Typhoid treatment Market in 2019 with a share of xx.x%. Growing research activities, advanced treatment techniques, favorable reimbursement policies, development of novel products are the multiple factors boosting the growth of the market in this region. Moreover, the efforts of key players in developing new and efficient drug pipelines is boosted the regional demand for the market.

The Asia Pacific is expected to witness growth in the forecast period. Owing to the increasing population and rising typhoid cases, growing healthcare facilities in developing nations, and advanced treatment options, the market in this region is anticipated to grow. Moreover, increasing medical tourism in the region is expected to drive the market.

Key Players in the Global Typhoid Treatment Market

• GlaxoSmithKline

• Bharat Biotech

• Bayer

• Sanofi S.A

• Pfizer

The report also helps in understanding Global Typhoid Treatment Market dynamics, structure by analysing the market segments and project the Global Typhoid Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Typhoid Treatment Market make the report investor’s guide.

For more information of visit:https://www.maximizemarketresearch.com/market-report/global-typhoid-treatment-market/82862/

This Report Is Submitted By : Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.